Citation only
via OpenAlex
Muscle‐Specific Calpastatin Overexpression Prevents Sarcopenia of Aging
Elizabeth A. Schroder, Xiaohong Song, Lin Wang, Gerald S. Supinski, Leigh Ann Callahan
The FASEB Journal · 2017
Abstract
Sarcopenia is a major cause of disability. The precise mechanisms responsible for aging‐related muscle weakness and atrophy are not known. However, recent studies suggest that pathologic activation of calpain modulates skeletal muscle dysfunction in aging. We tested the hypothesis that skeletal muscle‐specific overexpression of calpastatin, the endogenous inhibitor of calpain, would ameliorate aging‐associated decrements in muscle function. Five month old and 25 month old wild type (WT) and muscle‐specific calpastatin overexpressing (CalpOX) male mice (n=23) were studied. Grip strength was used as an index of total forelimb strength. To assess hindlimb strength, we measured extensor digitorum longus (EDL) mass and muscle specific force generation. Aging significantly reduced fore‐limb grip strength (0.94 ± 0.06 vs 1.47 ± 0.06N for old WT vs young WT, respectively, p<0.001). Importantly, calpastatin overexpression mitigated the aging‐induced reductions in fore‐limb grip strength (0.94 ± 0.06 vs 1.22 ± 0.05 for old WT vs old CalpOX, respectively, p=0.007). Aging also induced loss of EDL mass; calpastatin overexpression significantly ameliorated these reductions (7.63 ± 0.33 vs. 9.17 ± 0.45 mg for old WT vs old CalpOX, respectively, p=0.02). While calpastatin overexpression increased EDL muscle mass, EDL force per unit mass was similar between old WT and old CalpOX animals. To our knowledge, this is the first report of the effects of muscle‐specific calpastatin overexpression on skeletal muscle function in aging rodents. These findings support the concept that calpain activation plays a role in aging‐induced sarcopenia. We speculate that therapeutic agents which attenuate calpain activation may preserve muscle function in the elderly. Support or Funding Information R01HL112085, 5I01BX002132, R01HL113494
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1096/fasebj.31.1_supplement.713.4
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Schroder, E.A., Song, X., Wang, L., Supinski, G.S., & Callahan, L.A. (2017). Muscle‐Specific Calpastatin Overexpression Prevents Sarcopenia of Aging. <em>The FASEB Journal</em>. https://doi.org/10.1096/fasebj.31.1_supplement.713.4
Vancouver
Schroder EA, Song X, Wang L, Supinski GS, Callahan LA. Muscle‐Specific Calpastatin Overexpression Prevents Sarcopenia of Aging. The FASEB Journal. 2017. doi:10.1096/fasebj.31.1_supplement.713.4.
BibTeX
@article{elizabeth2017Muscle,
title = {Muscle‐Specific Calpastatin Overexpression Prevents Sarcopenia of Aging},
author = {Elizabeth A. Schroder and Xiaohong Song and Lin Wang and Gerald S. Supinski and Leigh Ann Callahan},
journal = {The FASEB Journal},
year = {2017},
doi = {10.1096/fasebj.31.1_supplement.713.4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Science 2023
Open access · CC-BY
Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men
Aging Cell 2012
Open access · OA
Age‐related loss of nitric oxide synthase in skeletal muscle causes reductions in calpainS‐nitrosylation that increase myofibril degradation and sarcopenia
Drugs & Aging 2016
Citation only
Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II)
Seoul National University Bundang Hospital 2017
Open access · US-GOV
Effects of Eccentric-based Training on Muscle Strength and Physical Function in Older Adults
Redox Biology 2018
Open access · CC-BY
Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass
Autophagy 2024
Open access · CC-BY